DSpace About icddr,b  

DSpace at icddr,b >
Infectious Diseases and Vaccine Sciences >
Infectious diseases and vaccine sciences research papers >


Title: Zinc supplementation in the management of shigellosis in malnourished children in Bangladesh
Authors: Roy, S.K.
Raqib, R .
Khatun, W.
Chowdhury, R.
Azim, T.
Fuchs, G.J.
Sack, D.A.
Keywords: Shigella
Zinc supplementation
Diarrhea, Infantile
Issue Date: Apr-2007
Series/Report no.: European Journal of Clinical Nutrition
2007 April:1-7
Abstract: Objective: To assess the impact of zinc supplementation on clinical recovery, weight gain and subsequent growth and morbidity in moderately malnourished children with shigellosis. Design: A randomized, double-blind, controlled trial. Setting: Dhaka hospital of ICDDR,B: Centre for Health and Population Research, Dhaka, Bangladesh. Subjects: Fifty-six moderately malnourished children, aged 12–59 months with culture-proven shigellosis. Methods: Subjects were randomly allocated to receive zinc (20 mg/day elemental) in multivitamin syrup (intervention) or multivitamin syrup without zinc (control) in two equally divided doses daily for 2 weeks. All children received pivmecillinam in a dose of 15 mg/kg every 6 h for 5 days. After supplementation, children were followed in their respective homes every 2 weeks for 6 months. Results: Children receiving zinc recovered from acute illness significantly faster than the control children (Po0.05). The medians time (days) to recovery and disappearances of blood and mucous were significantly 50% shorter in the zinc-supplemented group compared to the control group. The mean body weight of zinc supplemented children increased significantly from 8.8 kg on admission to 9.2 kg (Po0.01) at recovery, which was not observed in the control children (from 9.3 to 9.6 kg; P¼0.12). During the 6-month follow-up period, zinc-supplemented children had significantly fewer mean episodes of diarrhoea compared to the control children (2.2 vs 3.3; P¼0.03). Conclusion: Zinc supplementation significantly shortens the duration of acute shigellosis, promotes better weight gain during recovery and reduces diarrhoeal morbidity during the subsequent 6 months. European Journal of Clinical Nutrition advance online publication, 30 May 2007; doi:10.1038/sj.ejcn.1602795
URI: http://hdl.handle.net/123456789/604
Appears in Collections:Infectious diseases and vaccine sciences research papers

Files in This Item:

File Description SizeFormat
2007-EurJClinNutr-1-RoySK.pdf98KbAdobe PDFView/Open

This item is protected by original copyright

All items in DSpace are protected by copyright, with all rights reserved.


Valid XHTML 1.0! DSpace Software Copyright © 2002-2006 MIT and Hewlett-Packard - Feedback